Cargando…
Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
Chemotherapeutic intervention remains the primary strategy in treating and controlling tuberculosis (TB). However, a complex interplay between therapeutic and patient-related factors leads to poor treatment adherence. This in turn continues to give rise to unacceptably high rates of disease relapse...
Autores principales: | Afkhami, Sam, Villela, Anne Drumond, D’Agostino, Michael R., Jeyanathan, Mangalakumari, Gillgrass, Amy, Xing, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509172/ https://www.ncbi.nlm.nih.gov/pubmed/33013927 http://dx.doi.org/10.3389/fimmu.2020.557809 |
Ejemplares similares
-
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022) -
Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2023) -
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
por: Singh, Ramandeep, et al.
Publicado: (2021) -
Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells
por: Haddadi, Siamak, et al.
Publicado: (2019) -
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)